Shanghai Pharma swallows Cardinal Health’s China unit

The Chinese pharmaceutical firm offers $238 million to take Vitaco private, in the latest example of China’s huge interest in clean and green food products.

India’s largest multispecialty hospital network by bed capacity opened more than 10% above its offer price. In another deal, KKR has acquired Hyderabad-based hospital chain Medicover Hospitals India, as the country’s private healthcare market grows.

The DRAM manufacturer raised Rmb57.9bn ($8.6bn) in Asia’s largest IPO of 2026 so far and has become China’s largest onshore-listed company by market value, raising questions over the chip maker's valuation and growth prospects.

Shanghai has been handed more tools, including the acceleration of offshore loans and digital trade, to aid offshore financial services in a boost to the city as a global financial hub; there is also cooperation with Hong Kong.

China's outbound M&A activity reached a new record in the first half, putting it on track for a strong year, says PwC.

Shanghai Pharma's IPO beats the odds to find good demand in difficult market conditions.